116 related articles for article (PubMed ID: 24000822)
1. Exploring mode of phosphoramidon and Aβ peptide binding to hECE-1 by molecular dynamics and docking studies.
Barage SH; Sonawane KD
Protein Pept Lett; 2014; 21(2):140-52. PubMed ID: 24000822
[TBL] [Abstract][Full Text] [Related]
2. Structural analysis of membrane-bound hECE-1 dimer using molecular modeling techniques: insights into conformational changes and Aβ1-42 peptide binding.
Sonawane KD; Barage SH
Amino Acids; 2015 Mar; 47(3):543-59. PubMed ID: 25501500
[TBL] [Abstract][Full Text] [Related]
3. Molecular dynamics simulation and molecular docking studies of Angiotensin converting enzyme with inhibitor lisinopril and amyloid Beta Peptide.
Jalkute CB; Barage SH; Dhanavade MJ; Sonawane KD
Protein J; 2013 Jun; 32(5):356-64. PubMed ID: 23660814
[TBL] [Abstract][Full Text] [Related]
4. In-silico characterization of ECE-1 inhibitors.
Ajay Babu P; Colluru VT; Anaparthy N
Comput Biol Med; 2012 Apr; 42(4):446-57. PubMed ID: 22245098
[TBL] [Abstract][Full Text] [Related]
5. Structure of human endothelin-converting enzyme I complexed with phosphoramidon.
Schulz H; Dale GE; Karimi-Nejad Y; Oefner C
J Mol Biol; 2009 Jan; 385(1):178-87. PubMed ID: 18992253
[TBL] [Abstract][Full Text] [Related]
6. Molecular modeling approach to explore the role of cathepsin B from Hordeum vulgare in the degradation of Aβ peptides.
Dhanavade MJ; Parulekar RS; Kamble SA; Sonawane KD
Mol Biosyst; 2016 Jan; 12(1):162-8. PubMed ID: 26568474
[TBL] [Abstract][Full Text] [Related]
7. A three-dimensional model of endothelin-converting enzyme (ECE) based on the X-ray structure of neutral endopeptidase 24.11 (NEP).
Bur D; Dale GE; Oefner C
Protein Eng; 2001 May; 14(5):337-41. PubMed ID: 11438756
[TBL] [Abstract][Full Text] [Related]
8. Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme.
Eckman EA; Reed DK; Eckman CB
J Biol Chem; 2001 Jul; 276(27):24540-8. PubMed ID: 11337485
[TBL] [Abstract][Full Text] [Related]
9. Homology modeling, molecular docking and MD simulation studies to investigate role of cysteine protease from Xanthomonas campestris in degradation of Aβ peptide.
Dhanavade MJ; Jalkute CB; Barage SH; Sonawane KD
Comput Biol Med; 2013 Dec; 43(12):2063-70. PubMed ID: 24290922
[TBL] [Abstract][Full Text] [Related]
10. Molecular modelling and site-directed mutagenesis of the active site of endothelin-converting enzyme.
Sansom CE; Hoang MV; Turner AJ
Protein Eng; 1998 Dec; 11(12):1235-41. PubMed ID: 9930673
[TBL] [Abstract][Full Text] [Related]
11. Dynamic changes in the secondary structure of ECE-1 and XCE account for their different substrate specificities.
Ul-Haq Z; Iqbal S; Moin ST
BMC Bioinformatics; 2012 Nov; 13():285. PubMed ID: 23113990
[TBL] [Abstract][Full Text] [Related]
12. Metallopeptide-promoted inactivation of angiotensin-converting enzyme and endothelin-converting enzyme 1: Toward dual-action therapeutics.
Gokhale NH; Cowan JA
J Biol Inorg Chem; 2006 Oct; 11(7):937-47. PubMed ID: 16874470
[TBL] [Abstract][Full Text] [Related]
13. Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations.
Hernández-Rodríguez M; Correa-Basurto J; Gutiérrez A; Vitorica J; Rosales-Hernández MC
Eur J Med Chem; 2016 Nov; 124():1142-1154. PubMed ID: 27639619
[TBL] [Abstract][Full Text] [Related]
14. Insights into the molecular interactions between aminopeptidase and amyloid beta peptide using molecular modeling techniques.
Dhanavade MJ; Sonawane KD
Amino Acids; 2014 Aug; 46(8):1853-66. PubMed ID: 24729013
[TBL] [Abstract][Full Text] [Related]
15. Constitutive phosphorylation of human endothelin-converting enzyme-1 isoforms.
MacLeod KJ; Husain RD; Gage DA; Ahn K
J Biol Chem; 2002 Nov; 277(48):46355-63. PubMed ID: 12244060
[TBL] [Abstract][Full Text] [Related]
16. Highly sensitive and selective fluorescence assays for rapid screening of endothelin-converting enzyme inhibitors.
Luciani N; de Rocquigny H; Turcaud S; Romieu A; Roques BP
Biochem J; 2001 Jun; 356(Pt 3):813-9. PubMed ID: 11389689
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a possible role of Stigmatella aurantiaca ACE in Aβ peptide degradation: a molecular modeling approach.
Jalkute CB; Sonawane KD
J Mol Microbiol Biotechnol; 2015; 25(1):26-36. PubMed ID: 25677850
[TBL] [Abstract][Full Text] [Related]
18. Dual effects of familial Alzheimer's disease mutations (D7H, D7N, and H6R) on amyloid β peptide: correlation dynamics and zinc binding.
Xu L; Chen Y; Wang X
Proteins; 2014 Dec; 82(12):3286-97. PubMed ID: 25137638
[TBL] [Abstract][Full Text] [Related]
19. Interaction mechanism exploration of HEA derivatives as BACE1 inhibitors by in silico analysis.
Wu Q; Li X; Gao Q; Wang J; Li Y; Yang L
Mol Biosyst; 2016 Apr; 12(4):1151-65. PubMed ID: 26915506
[TBL] [Abstract][Full Text] [Related]
20. Structural significance of Neprylysin from Streptococcus suis GZ1 in the degradation of Aβ peptides, a causative agent in Alzheimer's disease.
Kamble S; Barale S; Dhanavade M; Sonawane K
Comput Biol Med; 2021 Sep; 136():104691. PubMed ID: 34343891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
